ACUVUE 1-DAY TRUEYE NARAFILCON A
Report
- Report Number
- 1033553-2013-00058
- Event Type
- Injury
- Date Received
- June 28, 2013
- Date of Event
- September 1, 2012
- Report Date
- June 28, 2013
- Manufacturer
- VISTAKON
- Product Code
- LPM
- PMA / PMN Number
- K073485
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
IF ADDITIONAL INFORMATION IS RECEIVED, WILL REPORT WITHIN 30 DAYS OF RECEIPT. SERIOUS REPORTABLE EVENT TRENDS ARE REVIEWED QUARTERLY IN FRANCHISE MANAGEMENT REVIEW MEETINGS. NO EVALUATION WILL BE PERFORMED. NO CONCLUSIONS CAN BE DRAWN.
ON (B)(6) 2013 OUR AUTHORIZED REPRESENTATIVE CONTACT IN THE (B)(6) RECEIVED A YELLOW CARD VOLUNTARY REPORT FORM SUBMITTED BY AN OPTICIAN. THE FORM STATED "LOSS OF SIGHT RIGHT EYE, CHANCE OF LOSS OF SIGHT LEFT EYE." I SPOKE WITH THE OPTICIAN WHO REPORTED THAT THE PATIENT WAS INITIALLY SEEN BY A GENERAL PRACTITIONER AND TREATED FOR CONJUNCTIVITIS WITH CHLORAMPHENICOL. WHEN THE SYMPTOMS WORSENED, THE PATIENT WAS REFERRED TO AN OPHTHALMOLOGIST WHO DIAGNOSED FUSARIUM KERATITIS AND ADMITTED THE PATIENT TO THE HOSPITAL. A FORMAL REQUEST FOR RECORDS WAS SUBMITTED TO THE HOSPITAL BY FAX BUT ACCESS WAS DENIED DUE TO PRIVACY ACT CONCERNS. INFORMATION PROVIDED TO THE OPTICIAN BY A THIRD PARTY INFORMS THAT THE PATIENT HAS LOST VISION IN THE RIGHT EYE AND "THE CORNEA HAS BEEN REMOVED." WE ARE UNABLE TO CONFIRM THIS INFORMATION. THE OPTICIAN ALSO REPORTED A SECOND SIMILAR EVENT, WHICH WILL BE REPORTED SEPARATELY. EFFORTS TO CONTACT THE PATIENT ARE CONTINUING. PRODUCT HAS NOT BEEN MADE AVAILABLE FOR RETURN AND NO LOT INFORMATION WAS PROVIDED. A FORMAL REQUEST FOR RECORDS WAS SUBMITTED TO THE HOSPITAL BY FAX BUT ACCESS WAS DENIED DUE TO PRIVACY ACT CONCERNS. WE ARE UNABLE TO CONFIRM THIS INFORMATION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 296299 | ACUVUE 1-DAY TRUEYE NARAFILCON A | SOFT CONTACT LENS | LPM | VISTAKON | NA | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 51 YR | Hospitalization| S |